Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

Author： Bogado1 César E   Massari2 Fabio E   Zanchetta3 José R  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.3, 2006-05, pp. : 447-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women

By Adami Silvano  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3259-3274

Informa Healthcare

Access to resources Recommend Favorite

The use of teriparatide and PTH(1–84) for the treatment of osteoporosis

By Wagman Rachel   Miller Paul  

Clinical Review in Bone and Mineral Metabolism, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-290

Humana Press, Inc

Access to resources Recommend Favorite

Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

By Lasco A.   Catalano A.   Morabito N.   Gaudio A.   Basile G.   Trifiletti A.   Atteritano M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 299-303

Springer Publishing Company

Access to resources Recommend Favorite

Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis

By Migliore A.   Broccoli S.   Massafra U.   Bizzi E.   Frediani B.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 467-473

Informa Healthcare

Access to resources Recommend Favorite

Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis

By  

CLINICAL ENDOCRINOLOGY, Vol. 85, Iss. 4, 2016-10 ,pp. : 556-560

John Wiley & Sons Inc

Access to resources Recommend Favorite